Open access · CC-BY
via OpenAlex
Proteomic architecture of frailty across the spectrum of cardiovascular disease
Andrew Perry, Shilin Zhao, Priya Gajjar, Venkatesh Locharla Murthy, Benoit Lehallier, Patricia Miller, Sangeeta Nair, Colin Neill, J. Jeffrey Carr, William Fuller Fearon, Samir Ramesh Kapadia, Dharam J. Kumbhani, Linda D. Gillam, JoAnn M. Lindenfeld, Laurie A Farrell
Aging Cell · 2023 · ▲ 9 citations
Abstract
While frailty is a prominent risk factor in an aging population, the underlying biology of frailty is incompletely described. Here, we integrate 979 circulating proteins across a wide range of physiologies with 12 measures of frailty in a prospective discovery cohort of 809 individuals with severe aortic stenosis (AS) undergoing transcatheter aortic valve implantation. Our aim was to characterize the proteomic architecture of frailty in a highly susceptible population and study its relation to clinical outcome and systems-wide phenotypes to define potential novel, clinically relevant frailty biology. Proteomic signatures (specifically of physical function) were related to post-intervention outcome in AS, specifying pathways of innate immunity, cell growth/senescence(definition), fibrosis/metabolism, and a host of proteins not widely described in human aging. In published cohorts, the "frailty proteome" displayed heterogeneous trajectories across age (20-100 years, age only explaining a small fraction of variance) and were associated with cardiac and non-cardiac phenotypes and outcomes across two broad validation cohorts (N > 35,000) over ≈2-3 decades. These findings suggest the importance of precision biomarkers of underlying multi-organ health status in age-related morbidity and frailty.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1111/acel.13978
- Canonical
- link ↗
- Fetched
- 2026-10-14 MST
Cite this
APA
Perry, A., Zhao, S., Gajjar, P., Murthy, V.L., Lehallier, B., Miller, P., Nair, S., Neill, C., Carr, J.J., Fearon, W.F., Kapadia, S.R., Kumbhani, D.J., Gillam, L.D., Lindenfeld, J.M., Farrell, L.A., Marron, M.M., Tian, Q., Newman, A.B., Murabito, J.M., & Gerszten, R.E. (2023). Proteomic architecture of frailty across the spectrum of cardiovascular disease. <em>Aging Cell</em>. https://doi.org/10.1111/acel.13978
Vancouver
Perry A, Zhao S, Gajjar P, Murthy VL, Lehallier B, Miller P, et al. Proteomic architecture of frailty across the spectrum of cardiovascular disease. Aging Cell. 2023. doi:10.1111/acel.13978.
BibTeX
@article{andrew2023Proteo,
title = {Proteomic architecture of frailty across the spectrum of cardiovascular disease},
author = {Andrew Perry and Shilin Zhao and Priya Gajjar and Venkatesh Locharla Murthy and Benoit Lehallier and Patricia Miller and Sangeeta Nair and Colin Neill and J. Jeffrey Carr and William Fuller Fearon and Samir Ramesh Kapadia and Dharam J. Kumbhani and Linda D. Gillam and JoAnn M. Lindenfeld and Laurie A Farrell and Megan M. Marron and Qu Tian and Anne B. Newman and Joanne M. Murabito and Robert Edgardo Gerszten and Matthew Gregory Nayor and Sammy Elmariah and Brian R. Lindman and Ravi V. Shah},
journal = {Aging Cell},
year = {2023},
doi = {10.1111/acel.13978},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Carcinogenesis 2020
Preprint · OA
Targeting cellular senescence in cancer and aging: roles of p53 and its isoforms
medRxiv 2023
Preprint · CC-BY
Proteomic aging clock predicts mortality and risk of common age-related diseases in diverse populations
JCI Insight 2020
Open access · CC-BY
The senescence-associated secretome as an indicator of age and medical risk
Mutation Research/DNAging 1992
Citation only
An update on the mitochondrial-DNA mutation hypothesis of cell aging
Mechanisms of Ageing and Development 2017
Open access · CC-BY
Stress, cell senescence and organismal ageing
Nature Medicine 2026
Open access · CC-BY